Reimbursement models to tackle market failures for antimicrobials: Approaches taken in France, Germany, Sweden, the United Kingdom, and the United States-Reference-Cited by-同舟云学术

Reimbursement models to tackle market failures for antimicrobials: Approaches taken in France, Germany, Sweden, the United Kingdom, and the United States

Published:2021-03 Issue:3 Volume:125 Page:296-306
ISSN:0168-8510
Container-title:Health Policy
language:en
Short-container-title:Health Policy

Author:

Gotham Dzintars,Moja Lorenzo,van der Heijden Maarten,Paulin Sarah,Smith Ingrid,Beyer Peter

Funder

Ministry of Health of Germany

Publisher

Elsevier BV

Subject

Health Policy

Reference59 articles.

1. Antibacterial agents in preclinical development: an open access database;World Health Organization,2019

2. Towards a new global business model for antibiotics delinking revenues from sales: report from the chatham house working group on new antibiotic business models;Chatham House,2015

3. Tackling drug-resistant infections globally: final report and recommendations;The Review on Antimicrobial Resistance Chaired by Jim O’Neill,2016

4. Revitalizing the antibiotic pipeline: stimulating innovation while driving sustainable use and global access;DRIVE-AB,2018

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancing global antibiotic research, development and access;Nature Medicine;2024-09-03

2. Changes in revenues associated with antimicrobial reimbursement reforms in Germany;Humanities and Social Sciences Communications;2024-08-10

3. Bacteriophage therapy in the management of diabetic foot ulcer infections;Practical Diabetes;2024-08

4. Antibiotic shortages in Europe: Another question of prices?;European Journal of Internal Medicine;2024-07

5. Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally;Applied Health Economics and Health Policy;2024-06-05